"A Comparative Clinical Evaluation of the Efficacy of Topical Adapalene, Benzoyl Peroxide Gel, Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule, and Their Fixed Combination in Mild to Moderate Acne Vulgaris Patients."
NCT ID: NCT05855629
Last Updated: 2023-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
59 participants
INTERVENTIONAL
2022-02-18
2023-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of an Oral Probiotic Associated With a Fixed Combination of Benzoyl Peroxide and Adapalene in the Treatment of Acne
NCT05216289
A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris
NCT03615768
A Treatment for Severe Inflammatory Acne Subjects
NCT02899000
Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris
NCT00671749
Efficacy and Tolerance of Formula 609613 37 in Acneic Patients
NCT05469880
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Topical Adapalene, Benzoyl Peroxide Gel
Topical Adapalene, Benzoyl Peroxide Gel
Adapalene 1mg/g, Benzoyl Peroxide 25mg/ml
Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule
Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule
Lactobacillus Rhamnosus 1,5 х 10\*9, Inulin 25mg, D-chiro-inositol 250mg
Topical Adapalene,Benzoyl Peroxide Gel,Oral Lactobacillus Rhamnosus,D-chiro-inositol,Inulin Capsule
Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule
Lactobacillus Rhamnosus 1,5 х 10\*9, Inulin 25mg, D-chiro-inositol 250mg
Topical Adapalene, Benzoyl Peroxide Gel
Adapalene 1mg/g, Benzoyl Peroxide 25mg/ml
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule
Lactobacillus Rhamnosus 1,5 х 10\*9, Inulin 25mg, D-chiro-inositol 250mg
Topical Adapalene, Benzoyl Peroxide Gel
Adapalene 1mg/g, Benzoyl Peroxide 25mg/ml
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
27 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
delta medical promotions ag
UNKNOWN
Treatment and Diagnostic Center of Private Enterprise "Asklepiy"
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yuriy Andrashko
Yuriy Andrashko
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
TDC PE "Asklepiy"
Uzhhorod, Zakarpattia Oblast, Ukraine
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EDA1370
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.